Newsletters

In each newsletter, you can look forward to being introduced to our team members, pop-up news, clinical support (i.e. treatment/management guidelines), info about special compounds, and even pharmacy operational updates or advice.

August 2019

01 August 2019

In this month’s issue, you’ll be learning about the following: 

  • Our Creative Compounding and Care-Rx team members: Erika Arevalo, Pharm.D. and Michelle Gonzalez
  • The CDC’s recommendations for the expected national shortage in tuberculosis (TB) tests
  • What is a true penicillin allergy and the chances of cephalosporin cross-sensitivity

View Newsletter

  About

July 2019

01 July 2019

In this month’s issue, you’ll be learning about the following: 

  • Our Creative Compounding Pharmacy’s team members: Carol Allen and Hoang Nguyen
  • The rise in dexamethasone use in hospice care: its indications, dosing, benefits, side effects and monitoring parameters
  • Differentiating between a true opioid allergy vs. a pseudo-allergy or adverse effect & the risk of cross-sensitivity across different classes

View Newsletter

  About

June 2019

01 June 2019

In this month’s issue, you’ll be learning about the following:

  • The reason why loperamide is known as “the poor man’s methadone” and recommended treatments for a loperamide overdose
  • Treatment options for and the management of opioid-induced constipation

View Newsletter

  About

May 2019

01 May 2019

In this month’s issue, you’ll be learning about the following:

  • Our pharmacy’s team members: Jason Tran, Pharm.D (CEO/Owner) and Danielle Bashor (Executive Assistant/Business Operations Manager)
  • The surge in generic drug prices explained: lawsuit against our nation’s largest drug manufacturers

View Newsletter

  About

April 2019

01 April 2019

In this month’s issue, you’ll be learning about the following:

  • Our pharmacy’s team members Andy Vu, PharmD (Staff Pharmacist) and Vicky Serrano (Pharmacy Tech Supervisor)
  • **IMPORTANT: The DEA’s new regulations/tools for drug manufacturers and distributors, explaining why we had to adjust the quantity dispensed for Controlled Substances**

View Newsletter

  About